Seeking Alpha
View as an RSS Feed

Michael Slattery  

View Michael Slattery's Articles BY TICKER:
  • Novavax: Expect Chain Reaction In Stock Price From Multiple Catalytic Events
    Dec. 10, 2014 NVAX 31 Comments

    Summary

    • Novavax can make an effective vaccine to a completely new, unique and emerging disease faster than any other technology.
    • Making Novavax the vaccine platform of choice for emerging disease threats by foreign governments and the US.
    • Novavax possesses the best solution to pandemic plagues and accurate seasonal flu vaccines.
    • Novavax could have prevented the failure of this year's seasonal Flu Vaccine.
    • Strong Governmental votes of confidence through funding by BARDA and the NGO, Path exceeding $175 million.
  • Facebook: A Gold Mine Exposed By A Rift
    Editors' Pick • Nov. 27, 2014 FB 100 Comments

    Summary

    • Turning Virtual Reality into Virtual Profits.
    • Most investors still don’t understand what Facebook’s new product even is, and therefore have no idea of what the promise or the potential are.
    • Every market that will generate income, previously existed, but will now be expanded and tapped with an iTunes efficiency.
    • This article is an introduction and primer on the possibilities.
  • In Case Of MERS Emergency - Break Glass, Buy Novavax
    May. 20, 2014 NVAX 29 Comments

    Summary

    • Only Novavax has the science and production facilities to appropriately respond to an emerging MERS threat.
    • MERS infections are increasing dramatically, with 300 new infections reported by WHO in the last few weeks.
    • Investment opportunity is directly related to the number of new infections, and thus can be tracked and measured.
  • Novavax: A Unique Opportunity
    Editors' Pick • May. 15, 2014 NVAX 53 Comments

    Summary

    • Predictable Regulatory Approvals and Novel Financing - Equates to Low Risk and High Returns.
    • Significant profit opportunity in 3 to 18 months.
    • Recent RSV clinical results achieved dramatic breakthroughs in efficacy and safety.
    • Federal and Private, NGO investments provide independent votes of confidence.
    • Pandemic Flu and emerging MERS threats put Novavax at the vanguard of protecting global health from emerging pandemics.
  • Pandora's Acquisition Prospects Jump
    Oct. 10, 2012 P 23 Comments
  • Inventure Foods Demonstrating Fundamental And Technical Strength
    Apr. 11, 2012 SNAK Comment!
  • Cold Fusion: A Cure For High Gas Prices
    Mar. 2, 2012 ARVCF, DNN, UUUU 70 Comments
  • Is Lihua International Being Shorted Back To China?
    Nov. 27, 2011 LIWA 53 Comments
  • Lihua International, Inc.: Turning Copper Into Gold
    Nov. 17, 2011 LIWA 76 Comments
  • Telestone Tech: Rock Solid Chinese Stock With Huge Potential
    Oct. 23, 2011 TSTC 43 Comments
  • Sangamo's Phase II Results To Be Announced Monday - Expect Good News
    Oct. 2, 2011 SGMO 11 Comments
  • The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
    Sep. 28, 2011 SGMO 33 Comments
  • Sangamo's Late Breaking News: Time To Act
    Sep. 19, 2011 SGMO 12 Comments
  • Sangamo's Late Breaking, Game Changing News At ICAAC
    Sep. 1, 2011 SGMO 15 Comments
  • Steve Jobs' Job Went From CEO to COB, But Nothing Has Changed
    Aug. 25, 2011 AAPL 1 Comment
  • Sangamo BioScience: A Real Bargain Below $5
    Aug. 10, 2011 SGMO 4 Comments
  • Sangamo's Inevitable Acquisition/Merger
    May. 22, 2011 SGMO 11 Comments
  • Sangamo Biosciences' Game Changing Technology
    Apr. 20, 2011 SGMO 7 Comments
  • A Checklist for Safe Investing in Chinese Stocks
    Apr. 17, 2011 TSTC, DYP, CILE 57 Comments